A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.
Clinical trial NCT00332215 · TERMINATED
Trial details
- NCT number
- NCT00332215
- Sponsor
- University of Minnesota
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.